Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 118, Issue 5, Pages e2021579118
Publisher
Proceedings of the National Academy of Sciences
Online
2021-01-16
DOI
10.1073/pnas.2021579118
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- COVID-19—New Insights on a Rapidly Changing Epidemic
- (2020) Carlos del Rio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs
- (2020) Sangeun Jeon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID‐19
- (2020) Virginia D. Schmith et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Prioritisation of Anti‐SARS‐Cov‐2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics
- (2020) Usman Arshad et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The anti‐HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV‐2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID‐19 infections
- (2020) Farhana Musarrat et al. JOURNAL OF MEDICAL VIROLOGY
- Pathogenesis and transmission of SARS-CoV-2 in golden hamsters
- (2020) Sin Fun Sia et al. NATURE
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
- (2020) David E. Gordon et al. NATURE
- Structural basis of receptor recognition by SARS-CoV-2
- (2020) Jian Shang et al. NATURE
- Respiratory disease in rhesus macaques inoculated with SARS-CoV-2
- (2020) Vincent J. Munster et al. NATURE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
- (2020) Shutoku Matsuyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Site-specific glycan analysis of the SARS-CoV-2 spike
- (2020) Yasunori Watanabe et al. SCIENCE
- Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19)
- (2020) Giuseppe Lippi et al. ANNALS OF CLINICAL BIOCHEMISTRY
- The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control
- (2020) Yosra A. Helmy et al. Journal of Clinical Medicine
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
- (2020) Ka-Tim Choy et al. ANTIVIRAL RESEARCH
- α-glucosidase inhibitors as host-directed antiviral agents with potential for the treatment of COVID-19
- (2020) Spencer J. Williams et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding
- (2020) Tyler N. Starr et al. CELL
- The Global Phosphorylation Landscape of SARS-CoV-2 Infection
- (2020) Mehdi Bouhaddou et al. CELL
- Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?
- (2020) Marta Menegazzi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development
- (2020) Masaki Imai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Natural product-derived phytochemicals as potential agents against coronaviruses: A review
- (2020) Janice S. Mani et al. VIRUS RESEARCH
- SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
- (2020) Thomas Mandel Clausen et al. CELL
- A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures
- (2020) Kenneth H. Dinnon et al. NATURE
- Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein
- (2020) Lorenzo Casalino et al. ACS Central Science
- High-throughput Screening and Identification of Potent Broad-spectrum Inhibitors of Coronaviruses
- (2019) Liang Shen et al. JOURNAL OF VIROLOGY
- The Chemical Composition and Nutritional Value of Chia Seeds—Current State of Knowledge
- (2019) Bartosz Kulczyński et al. Nutrients
- Cepharanthine: An update of its mode of action, pharmacological properties and medical applications
- (2019) Christian Bailly PHYTOMEDICINE
- GISAID: Global initiative on sharing all influenza data – from vision to reality
- (2017) Yuelong Shu et al. Eurosurveillance
- Viral dependence on cellular ion channels – an emerging anti-viral target?
- (2017) Samantha Hover et al. JOURNAL OF GENERAL VIROLOGY
- Carnosic acid
- (2015) Simona Birtić et al. PHYTOCHEMISTRY
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Viral Membrane Channels: Role and Function in the Virus Life Cycle
- (2015) ChingWooen Sze et al. Viruses-Basel
- Continuous and Discontinuous RNA Synthesis in Coronaviruses
- (2015) Isabel Sola et al. Annual Review of Virology
- In vitro inhibition of the bovine viral diarrhoea virus by the essential oil of Ocimum basilicum (basil) and monoterpenes
- (2014) Thaís F. Kubiça et al. BRAZILIAN JOURNAL OF MICROBIOLOGY
- Immunization of fucose-containing polysaccharides from Reishi mushroom induces antibodies to tumor-associated Globo H-series epitopes
- (2013) Shih-Fen Liao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus
- (2012) Kylie M. Wagstaff et al. BIOCHEMICAL JOURNAL
- Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13
- (2012) Mi-Sun Yu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Patchouli alcohol: in vitro direct anti-influenza virus sesquiterpene in Pogostemon cablin Benth.
- (2011) Hiroaki Kiyohara et al. Journal of Natural Medicines
- Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
- (2008) Chi-Yuan Chou et al. BIOCHEMICAL PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started